Header Logo

Connection

YUKA MORIKAWA to Diabetic Nephropathies

Back to Details
This is a "connection" page, showing publications YUKA MORIKAWA has written about Diabetic Nephropathies.
YUKA MORIKAWA
Connection Strength
0.155
Diabetic Nephropathies
  1. Synergistic reduction in albuminuria in type 2 diabetic mice by esaxerenone (CS-3150), a novel nonsteroidal selective mineralocorticoid receptor blocker, combined with an angiotensin II receptor blocker. Hypertens Res. 2020 11; 43(11):1204-1213.
    View in: PubMed
    Score: 0.155
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.